Hemispherx BioPharma, Inc. (NYSEMKT:HEB)

CAPS Rating: 1 out of 5

A biopharmaceutical company engaged in the clinical development, manufacture, marketing and distribution of new drug entities based on natural immune system enhancing technologies for the treatment of viral and immune based chronic disorders.

Recs

0
Player Avatar pchop123 (79.76) Submitted: 11/15/2012 4:34:34 PM : Underperform Start Price: $0.75 HEB Score: -1.01

NOT OPTOMISTIC HERE

Featured Broker Partners


Advertisement